Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin

Blood

Volumn 99, Issue 2, 2002, Pages 680-689

  Stepkowski, Stanislaw M ^a,b,c   Erwin Cohen, Rebecca A ^a,b,c   Behbod, Fariba ^a,b,c   Wang, Mou Er ^a,b,c   Qu, Xienui ^a,b,c   Tejpal, Neelam ^a,b,c   Nagy, Zsuzsanna S ^a,b,c   Kahan, Barry D ^a,b,c   Kirken, Robert A ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ENZYME INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PNU 156804; PRODIGIOSIN; RAPAMYCIN; STAT PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0037079735     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.680     Document Type: Article

References (67)

1. Signal transduction by lymphocyte antigen receptors
2. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain
3. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency
4. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn
5. Transcriptional regulation of T lymphocyte development and function
6. JAKs and STATs: Biological implications
7. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4
8. Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor
9. Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor
10. Interaction of IL-2R beta and gamma c chains with Jakl and Jak3: Implications for XSCID and XCID
11. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain
12. Signal transduction by the TCR for antigen
13. Immunosuppressive strategies in transplantation
14. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
15. Overview: Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters
16. Immunopharmacology of rapamycin
17. Sirolimus (Rapamune, rapamycin) is more effective than azathioprine to reduce the incidence of acute renal allograft rejection episodes when used in combination with cyclosporine and prednisone: A phase III U.S. multicenter trial
18. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyctosporine on the synergistic prolongation of heart allograft survival in rats
19. Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine: Sirolimus European Renal Transplant Study Group
20. Mammalian target of rapamycin: Immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling
21. The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients
22. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations
23. Peripheral expression of Jak3 is required to maintain T lymphocyte function
24. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis
25. STATs and gene regulation
26. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
27. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells
28. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation of NF-κB and AP-1 activation
29. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells
30. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells
31. Improved technique of heart transplantation in rats
32. The median effect principle and the combination index for quantitation of synergism and antagonism
33. Models of inflammatory cascade reactions by adhesion molecules
34. The international society for heart and lung transplantation grading system for heart transplant biopsy specimens: Clarification and commentary
35. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways
36. Dispensability of Jakl tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line
37. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
38. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
39. Activation of receptor-associated tyrosine kinase JAK2 by prolactin
40. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha
41. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha
42. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases
43. Requirement of serine phosphorylation for formation of STAT-promoter complexes
44. Ser727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation
45. Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple STAT5 isoforms in Nb2 lymphocytes
46. Two discrete regions of interleukin-2 (IL2) receptor beta independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase
47. Analysis of interleukin-2-dependent signal transduction through the SHC/GRB2 adapter pathway: Interleukin-2-dependent mitogenesis does not require SHC phosphorylation or receptor association
48. Structural domains of IL-2 receptor beta critical for signal transduction: Kinase association and nuclear complex formation
49. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase
50. Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase
51. Long-term follow-up of a prospective trial of low-dose versus high-dose steroids in cadaveric renal transplantation
52. Two paradigms for new immunosuppressive strategies in organ transplantation
53. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
54. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG490 regulation of IL-2-mediated T cell response
55. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
56. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II-and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
57. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes
58. Concomitant inhibition of Jak3- and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts
59. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
60. IL-2 and IL-4 double knockout mice reject islet allografts: A role for novel T cell growth factors in allograft rejection
61. Interleukin 2 and its receptors: Recent advances and new immunological functions
62. CD40-CD40 ligand
63. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells
64. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis
65. Activation of the Janus kinase 3-STAT5a pathway after CD40 triggering of human monocytes but not of resting B cells
66. Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection